908 Devices Inc

For the period ended Dec 31, 2023. Filed Mar 8, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 8, 2024

MASS$9.99-13.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 8. Consolidated Statements of Cash Flows

Consolidated Statements of Cash Flows

(in thousands)


· · Year Ended December 31,
· 2023 · 2022
Cash flows from operating activities: · · · ·
Net loss	$(36,399)	$(33,563)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	2,384	1,614
Stock-based compensation expense	9,787	7,207
Noncash interest expense and loss on extinguishment of debt	192	47
Provision for inventory obsolescence	663	376
Net amortization of premiums and accretion of discounts on marketable securities	(301)	—
Provision for credit losses	386	—
Change in fair value of contingent consideration	107	161
Deferred income tax	(305)	(129)
Changes in operating assets and liabilities:
Accounts receivable, net	680	5,930
Inventory	(3,902)	(5,475)
Prepaid expenses and other current assets	(513)	844
Other long-term assets	(135)	(93)
Accounts payable and accrued expenses	2,033	452
Deferred revenue	179	1,892
Right-of-use operating lease assets	1,668	1,226
Operating lease liabilities	(1,583)	(1,344)
Other long-term liabilities	—	(75)
Net cash used in operating activities	(25,059)	(20,930)
Cash flows from investing activities:
Purchases of property and equipment	(2,045)	(2,045)
Purchases of marketable securities	(48,874)	—
Proceeds from sales and maturities of marketable securities	24,519	—
Acquisitions, net of cash acquired	—	(13,762)
Net cash used in investing activities	(26,400)	(15,807)
Cash flows from financing activities:
Payments for withholding taxes on vested awards	(776)	(262)
Proceeds from issuance of common stock	936	1,553
Payments of public offering costs	—	(112)
Proceeds from borrowings on revolving line of credit	—	60,000
Repayment on revolving line of credit	(15,000)	(60,000)
Payments for contingent consideration	(1,095)	—
Net cash (used in) provided by financing activities	(15,935)	1,179
Effect of foreign exchange rate changes on cash and cash equivalents	13	18
Net decrease in cash, cash equivalents and restricted cash	(67,381)	(35,540)
Cash, cash equivalents and restricted cash at beginning of period	188,593	224,133
Cash, cash equivalents and restricted cash at end of period	$121,212	$188,593
Supplemental disclosure of noncash investing and financing information:
Property and equipment included in account payable	$23	$219
Transfers of inventory to property and equipment	$1,047	$887
Transfers of property and equipment to inventory	$214	$—
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	$121,041	$188,422
Restricted cash included in prepaid expenses and other current assets	—	60
Restricted cash included in other long-term assets	171	111
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	$121,212	$188,593
Supplemental disclosure of cash flow information:
Cash paid for interest	$—	$135

Notes to Consolidated Financial Statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.